1Albert M.Of Time and Experience .Sarcoidosis Revisited Chest.2002,121(1):3-5.
2Marc A,Judson MD.An Approach to the Treatment of Pulmonary Sarcoidosis With Corticosteroids:The Six Phases of Treatment.Chest,1999,115(4):1158-1165.
3Johns CJ,Michele TM.The clinical management of sarcoidosis:a 50-year experience at the Johns Hopkins hospital.Medicine,1999,78(2):65-111.
4ATS/ERS/WASOG statement on sarcoidosis.Sarcoidosis Statement Committee.American Thoracic Society.European Respiratory Society.World Association for Sarcoidosis and Other Granulomatous Disorders.Eur Respir J,1999,14(4):735-737.
5Marc A,Judson F.An Approach to the Treatment of Pulmonary Sarcoidosis With Corticosteroids:The Six Phases of Treatment.Chest,1999,115(4):1158-1165.
6Baughman RP,Iannuzzi MC,Lower EE.Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis,2002,19(3):198-204.
7Baughman RP,Lower EE.A clinical approach to the use of methotrexate for sarcoidosis.Thorax,1999,54(8):742-746.
8Baughman RP,Winget DB,Lower EE.Methotrexate is steroid sparing in acute sarcoidosis:results of a double blind,randomized trial.Sarcoidosis Vasc Diffuse Lung Dis,2000,17(1):60-66.
9Zajicek JP,Scolding NJ,Foster O,et al.Central nervous system sarcoidosis-diagnosis and management.Q J Med,1999,92(2):103-117.
10Lewis SJ,Ainslie GM,Bateman ED.Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis,1999,16(1):87-92.
二级参考文献15
1Poulakis N;Androutsos G;Kazi D.The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications[J],1999(1).
2Ward A;Clissold SP.Pentoxifylline.A review of its pharmacody- namic and pharmacokinetic properties,and its therapeutic efficacy[J],1987.
3HANJ;Thompson P;Beutler B.Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway[J],1990.
4Marques LJ;Zheng L;Poulakis N.Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages[J],1999.
5Neuner P;Klosner E;Schauer E.Pentoxifylline in vivo down-regulates the release of IL-1beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells,1994.
6D′Hellencourt CL;Diaw L;Cornillet P.Differential regulation of TNF-alpha, IL-1beta, IL-6, IL-8, TNF-beta, and IL-10 by pentoxifylline[J],1996.
7Benbernou N;Esnault S;Potron G.Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells[J],1995.
8Bienvenu J;Doche C;Gutowski MC.Production of proinflammatory cytokines and cytokines involved in the Th1/Th2 balance is modulated by pentoxifylline[J],1995.
9Costabel U.Sarcoidosis: clinical update,2001.
10Hunninghake GW;Costabel U;Ando M.ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis[J],1999.
